Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 3 |
2014 | 2 |
2015 | 3 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).
Channels (Austin). 2015;9(6):336-43. doi: 10.1080/19336950.2015.1071748. Epub 2015 Jul 28.
Channels (Austin). 2015.
PMID: 26217968
Free PMC article.
Review.
Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets.
Wulff H, Köhler R.
Wulff H, et al.
J Cardiovasc Pharmacol. 2013 Feb;61(2):102-12. doi: 10.1097/FJC.0b013e318279ba20.
J Cardiovasc Pharmacol. 2013.
PMID: 23107876
Free PMC article.
Review.
Item in Clipboard
The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.
Lam J, Coleman N, Garing AL, Wulff H.
Lam J, et al.
Expert Opin Ther Targets. 2013 Oct;17(10):1203-20. doi: 10.1517/14728222.2013.823161. Epub 2013 Jul 25.
Expert Opin Ther Targets. 2013.
PMID: 23883298
Free PMC article.
Review.
Item in Clipboard
New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N, Brown BM, Oliván-Viguera A, Singh V, Olmstead MM, Valero MS, Köhler R, Wulff H.
Coleman N, et al.
Mol Pharmacol. 2014 Sep;86(3):342-57. doi: 10.1124/mol.114.093286. Epub 2014 Jun 23.
Mol Pharmacol. 2014.
PMID: 24958817
Free PMC article.
Item in Clipboard
Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.
Jenkins DP, Yu W, Brown BM, Løjkner LD, Wulff H.
Jenkins DP, et al.
Assay Drug Dev Technol. 2013 Nov-Dec;11(9-10):551-60. doi: 10.1089/adt.2013.543.
Assay Drug Dev Technol. 2013.
PMID: 24351043
Free PMC article.
Item in Clipboard
The riluzole derivative 2-amino-6-trifluoromethylthio-benzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant.
Coleman N, Nguyen HM, Cao Z, Brown BM, Jenkins DP, Zolkowska D, Chen YJ, Tanaka BS, Goldin AL, Rogawski MA, Pessah IN, Wulff H.
Coleman N, et al.
Neurotherapeutics. 2015 Jan;12(1):234-49. doi: 10.1007/s13311-014-0305-y.
Neurotherapeutics. 2015.
PMID: 25256961
Free PMC article.
Item in Clipboard
A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
Oliván-Viguera A, Valero MS, Coleman N, Brown BM, Laría C, Murillo MD, Gálvez JA, Díaz-de-Villegas MD, Wulff H, Badorrey R, Köhler R.
Oliván-Viguera A, et al.
Mol Pharmacol. 2015 Feb;87(2):338-48. doi: 10.1124/mol.114.095745. Epub 2014 Dec 2.
Mol Pharmacol. 2015.
PMID: 25468883
Free PMC article.
Item in Clipboard
Cite
Cite